Amgen Inc.

AMGN NAS
Pharmaceuticals
Thousand Oaks, CA
2016 Revenue (US$ Millions)$22,991
Revenue Growth (%)6.14%
2015 Revenue (US$ Millions)$21,662
Net Income (US$ Millions)$7,722
Common Shares Outstanding (Millions)738.2
Earnings Per Share (US$)$10.24
Price to Earnings Ratio17.02
Total Equity (US$ Millions)$29,875
Return on Equity (%)27.50%
Long Term Debt (US$ Millions)$30,193
Debt to Equity Ratio (%)1.01%
Market Capitalization (US$ Millions)$107,932
Total Assets (US$ Millions)$77,626
Current Assets (US$ Millions)$46,010
Inventories (US$ Millions)$2,745
Current Liabilities (US$ Millions)$11,204
Cost Of Goods Sold (US$ Millions)$4,162
Asset Turnover0.31
Inventory Turnover1.61